Huapont Life to buy 70% stake in Swiss firm
By Wang Wen | China Daily | Updated: 2015-12-02 07:51
Huapont Life Sciences Co Ltd, a Chongqiong-based pharmaceutical maker, said on Tuesday it will buy a 70 percent stake in Swiss Biological Medicine Group Ltd with no more than 210 million yuan ($32.82 million).
The Swiss company owns Paracelsus Suisse, a holistic medicine center for tumor treatment, anti-aging therapies and treatment of chronic diseases.
Shares in Huapont Life closed 5.97 percent higher at 14.2 yuan on the Shenzhen Stock Exchange on Tuesday.
Photo
